Humana (HUM) to Release Earnings on Wednesday

Key Points

• Humana (HUM) will report Q4 2025 results before the market opens on Feb 11, 2026 at 8:00 AM ET, with analysts forecasting EPS of ($4.01) and revenue of about $32.08 billion.
• Last quarter Humana posted $3.24 EPS and $32.65 billion in revenue (up 11.1% YoY); the stock carries an average analyst rating of Hold with an average price target of $293.21, a market cap around $23.2B and a P/E near 18.1.

Humana (NYSE:HUM - Get Free Report) is anticipated to announce its Q4 2025 results before the market opens on Wednesday, February 11th. Analysts expect Humana to post earnings of ($4.01) per share and revenue of $32.0804 billion for the quarter. Interested persons are encouraged to explore the company's upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, February 11, 2026 at 8:00 AM ET.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.02% and a return on equity of 12.86%. The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period in the prior year, the firm posted $4.16 EPS. The firm's revenue was up 11.1% compared to the same quarter last year. On average, analysts expect Humana to post $16 EPS for the current fiscal year and $13 EPS for the next fiscal year.

Humana Stock Performance

Humana stock opened at $192.95 on Wednesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The firm has a market capitalization of $23.21 billion, a P/E ratio of 18.08, a price-to-earnings-growth ratio of 1.55 and a beta of 0.44. Humana has a 1-year low of $186.00 and a 1-year high of $315.35. The company's 50-day moving average is $254.70 and its 200 day moving average is $263.84.

Hedge Funds Weigh In On Humana

A number of large investors have recently bought and sold shares of the business. Larson Financial Group LLC increased its holdings in shares of Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider's stock valued at $40,000 after acquiring an additional 81 shares during the period. Teza Capital Management LLC boosted its position in Humana by 9.4% during the second quarter. Teza Capital Management LLC now owns 1,255 shares of the insurance provider's stock valued at $307,000 after purchasing an additional 108 shares in the last quarter. Sunbelt Securities Inc. grew its stake in Humana by 18.1% in the third quarter. Sunbelt Securities Inc. now owns 719 shares of the insurance provider's stock valued at $187,000 after purchasing an additional 110 shares during the last quarter. Fulcrum Asset Management LLP bought a new position in Humana in the third quarter worth about $42,000. Finally, Geneos Wealth Management Inc. lifted its position in shares of Humana by 40.3% during the second quarter. Geneos Wealth Management Inc. now owns 571 shares of the insurance provider's stock valued at $140,000 after buying an additional 164 shares during the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on HUM shares. Zacks Research lowered Humana from a "hold" rating to a "strong sell" rating in a research note on Thursday, January 1st. Morgan Stanley reiterated an "underperform" rating on shares of Humana in a research note on Thursday, December 18th. Truist Financial lowered their target price on shares of Humana from $300.00 to $285.00 and set a "hold" rating for the company in a research note on Monday, November 10th. KeyCorp reaffirmed a "sector weight" rating on shares of Humana in a research note on Friday, December 12th. Finally, Sanford C. Bernstein reiterated an "outperform" rating and set a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Eight analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $293.21.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.